Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma

Background. Although thrombolytic therapy has been shown to be beneficial to stroke patients, the effectiveness of intravenous thrombolysis in ischemic stroke patients with ventricle myxoma is unknown. Case Description. A 22-year-old woman with left hemiplegia was sent to the emergency department at...

Full description

Bibliographic Details
Main Authors: Cheung-Ter Ong, Rei-Yeuh Chang
Format: Article
Language:English
Published: Hindawi Limited 2011-01-01
Series:Stroke Research and Treatment
Online Access:http://dx.doi.org/10.4061/2011/735057
id doaj-c48e2505c13e4c94bb3771576f4c3e54
record_format Article
spelling doaj-c48e2505c13e4c94bb3771576f4c3e542021-07-02T06:06:44ZengHindawi LimitedStroke Research and Treatment2042-00562011-01-01201110.4061/2011/735057735057Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular MyxomaCheung-Ter Ong0Rei-Yeuh Chang1Department of Neurology, Chia-Yi Christian Hospital, 539 Chung-Shao Road, Chia-Yi 60002, TaiwanDepartment of Cardiology, Chia-Yi Christian Hospital, 539 Chung-Shao Road, Chia-Yi 60002, TaiwanBackground. Although thrombolytic therapy has been shown to be beneficial to stroke patients, the effectiveness of intravenous thrombolysis in ischemic stroke patients with ventricle myxoma is unknown. Case Description. A 22-year-old woman with left hemiplegia was sent to the emergency department at a teaching hospital. The magnetic resonance angiography showed occlusion of the right middle cerebral artery, and the echocardiography showed a mass in the left ventricle. Intravenous recombined tissue plasminogen activator (rt-PA) was administrated, and the postthrombolysis transcranial Doppler exam showed that her right middle cerebral artery was circulative. The patient's condition improved gradually, and no complication was observed up to 16 months of follow-up. Conclusion. Intravenous rt-PA is a reasonable treatment for stroke patients with ventricle myxoma.http://dx.doi.org/10.4061/2011/735057
collection DOAJ
language English
format Article
sources DOAJ
author Cheung-Ter Ong
Rei-Yeuh Chang
spellingShingle Cheung-Ter Ong
Rei-Yeuh Chang
Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
Stroke Research and Treatment
author_facet Cheung-Ter Ong
Rei-Yeuh Chang
author_sort Cheung-Ter Ong
title Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
title_short Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
title_full Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
title_fullStr Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
title_full_unstemmed Intravenous Thrombolysis of Occlusion in the Middle Cerebral and Retinal Arteries from Presumed Ventricular Myxoma
title_sort intravenous thrombolysis of occlusion in the middle cerebral and retinal arteries from presumed ventricular myxoma
publisher Hindawi Limited
series Stroke Research and Treatment
issn 2042-0056
publishDate 2011-01-01
description Background. Although thrombolytic therapy has been shown to be beneficial to stroke patients, the effectiveness of intravenous thrombolysis in ischemic stroke patients with ventricle myxoma is unknown. Case Description. A 22-year-old woman with left hemiplegia was sent to the emergency department at a teaching hospital. The magnetic resonance angiography showed occlusion of the right middle cerebral artery, and the echocardiography showed a mass in the left ventricle. Intravenous recombined tissue plasminogen activator (rt-PA) was administrated, and the postthrombolysis transcranial Doppler exam showed that her right middle cerebral artery was circulative. The patient's condition improved gradually, and no complication was observed up to 16 months of follow-up. Conclusion. Intravenous rt-PA is a reasonable treatment for stroke patients with ventricle myxoma.
url http://dx.doi.org/10.4061/2011/735057
work_keys_str_mv AT cheungterong intravenousthrombolysisofocclusioninthemiddlecerebralandretinalarteriesfrompresumedventricularmyxoma
AT reiyeuhchang intravenousthrombolysisofocclusioninthemiddlecerebralandretinalarteriesfrompresumedventricularmyxoma
_version_ 1721337740638814208